Literature DB >> 8370584

Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10.

A E Karlbom1, C D James, J Boethius, W K Cavenee, V P Collins, M Nordenskjöld, C Larsson.   

Abstract

A panel of glial tumors consisting of 11 low grade gliomas, 9 anaplastic gliomas, and 29 glioblastomas were analyzed for loss of heterozygosity by examining at least one locus for each chromosome. The frequency of allele loss was highest among the glioblastomas, suggesting that genetic alterations accumulate during glial tumor development. The most common genetic alteration detected involved allele losses of chromosome 10 loci; these losses were observed in all glioblastomas and in three of the anaplastic gliomas. In order to delineate which chromosome 10 region or regions were deleted in association with glial tumor development, a deletion mapping analysis was performed, and this revealed the partial loss of chromosome 10 in eight glioblastomas and two of the anaplastic gliomas. Among these cases, three distinct regions of chromosome 10 were indicated as being targeted for deletion: one telomeric region on 10p and both telomeric and centromeric locations on 10q. These data suggest the existence of multiple chromosome 10 tumor suppressor gene loci whose inactivation is involved in the malignant progression of glioma.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8370584     DOI: 10.1007/bf00219686

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  34 in total

Review 1.  Report of the committee on the genetic constitution of chromosome 10.

Authors:  N E Simpson; H Cann
Journal:  Cytogenet Cell Genet       Date:  1990

2.  A genetic linkage map of 32 loci on human chromosome 10.

Authors:  D W Bowden; T C Gravius; P Green; K Falls; D Wurster-Hill; W Noll; H Müller-Kahle; H Donis-Keller
Journal:  Genomics       Date:  1989-11       Impact factor: 5.736

3.  Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails.

Authors:  A J Ekstrand; N Sugawa; C D James; V P Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

4.  Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin.

Authors:  T A Libermann; H R Nusbaum; N Razon; R Kris; I Lax; H Soreq; N Whittle; M D Waterfield; A Ullrich; J Schlessinger
Journal:  Nature       Date:  1985 Jan 10-18       Impact factor: 49.962

5.  Evidence for rearrangement, amplification, and expression of c-myc in a human glioblastoma.

Authors:  J Trent; P Meltzer; M Rosenblum; G Harsh; K Kinzler; R Mashal; A Feinberg; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

6.  Mutations in the p53 gene occur in diverse human tumour types.

Authors:  J M Nigro; S J Baker; A C Preisinger; J M Jessup; R Hostetter; K Cleary; S H Bigner; N Davidson; S Baylin; P Devilee
Journal:  Nature       Date:  1989-12-07       Impact factor: 49.962

7.  Mitotic recombination of chromosome 17 in astrocytomas.

Authors:  C D James; E Carlbom; M Nordenskjold; V P Collins; W K Cavenee
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

8.  Loss of heterozygosity on chromosome 10 in human glioblastoma multiforme.

Authors:  M Fujimoto; D W Fults; G A Thomas; Y Nakamura; M P Heilbrun; R White; J L Story; S L Naylor; K S Kagan-Hallet; P J Sheridan
Journal:  Genomics       Date:  1989-02       Impact factor: 5.736

9.  Four separate regions on chromosome 17 show loss of heterozygosity in familial breast carcinomas.

Authors:  A Lindblom; L Skoog; T I Andersen; S Rotstein; M Nordenskjöld; C Larsson
Journal:  Hum Genet       Date:  1993-03       Impact factor: 4.132

10.  p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.

Authors:  D Fults; D Brockmeyer; M W Tullous; C A Pedone; R M Cawthon
Journal:  Cancer Res       Date:  1992-02-01       Impact factor: 12.701

View more
  30 in total

1.  Proliferation and motility responses of primary and recurrent gliomas related to changes in epidermal growth factor receptor expression.

Authors:  M E Berens; M D Rief; J R Shapiro; D Haskett; A Giese; A Joy; S W Coons
Journal:  J Neurooncol       Date:  1996-01       Impact factor: 4.130

2.  Deletion mapping of gliomas suggest the presence of two small regions for candidate tumor-suppressor genes in a 17-cM interval on chromosome 10q.

Authors:  R Albarosa; B M Colombo; L Roz; I Magnani; B Pollo; N Cirenei; C Giani; A M Conti; S DiDonato; G Finocchiaro
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

3.  Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter.

Authors:  H Fujisawa; M Kurrer; R M Reis; Y Yonekawa; P Kleihues; H Ohgaki
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

4.  PAX6 suppresses growth of human glioblastoma cells.

Authors:  Yi-Hong Zhou; Xiaosong Wu; Fang Tan; Yue-Xi Shi; Tricia Glass; T J Liu; Kyle Wathen; Kenneth R Hess; Joy Gumin; Frederick Lang; W K Alfred Yung
Journal:  J Neurooncol       Date:  2005-02       Impact factor: 4.130

Review 5.  LGI1: a gene involved in epileptogenesis and glioma progression?

Authors:  W Gu; E Brodtkorb; T Piepoli; G Finocchiaro; O K Steinlein
Journal:  Neurogenetics       Date:  2005-04-13       Impact factor: 2.660

6.  Prevalence of copy-number neutral LOH in glioblastomas revealed by genomewide analysis of laser-microdissected tissues.

Authors:  Daisuke Kuga; Masahiro Mizoguchi; Yanlei Guan; Nobuhiro Hata; Koji Yoshimoto; Tadahisa Shono; Satoshi O Suzuki; Yoji Kukita; Tomoko Tahira; Shinji Nagata; Tomio Sasaki; Kenshi Hayashi
Journal:  Neuro Oncol       Date:  2008-08-12       Impact factor: 12.300

7.  In vitro loss of heterozygosity targets the PTEN/MMAC1 gene in melanoma.

Authors:  G P Robertson; F B Furnari; M E Miele; M J Glendening; D R Welch; J W Fountain; T G Lugo; H J Huang; W K Cavenee
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

Review 8.  Applications of emerging molecular technologies in glioblastoma multiforme.

Authors:  Hari R Kumar; Xiaoling Zhong; John A Sandoval; Robert J Hickey; Linda H Malkas
Journal:  Expert Rev Neurother       Date:  2008-10       Impact factor: 4.618

9.  Rapid detection of allelic losses in brain tumours using microsatellite repeat markers and high-performance liquid chromatography.

Authors:  O B Chernova; G H Barnett; J K Cowell
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640

10.  Glioblastoma Multiforme Oncogenomics and Signaling Pathways.

Authors:  Okezie O Kanu; Betsy Hughes; Chunhui Di; Ningjing Lin; Jinrong Fu; Darell D Bigner; Hai Yan; Cory Adamson
Journal:  Clin Med Oncol       Date:  2009-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.